Kraig Biocraft Laboratories, Inc. Enters Biomedical Field with First Sample Shipments of Fibers and Fabrics for Tissue Engineering
May 17, 2022 at 07:05 am EDT
Share
Kraig Biocraft Laboratories, Inc. announced the first sample shipment of its recombinant spider silk fibers and fabrics for use and evaluation into a range of biomedical applications. This shipment was made in response to the significant increase in the requests for its propriety spider silk technology, over the last two quarters, for tissue engineering applications. Aided by its unique blend of mechanical and chemical properties, spider silk has long been recognized as an ideal natural biomaterial. As a lightweight, biocompatible, and biodegradable material, spider silk applications have been tested in numerous morphologies, including; fibers, films, hydrogels, non-woven fabrics, foams, etc. While the first known cases of sutures made from spider silk date back to the 18th century, limitations in the production and costs of spider silk have prevented its broad adoption. Kraig Labs' revolutionary approach, creating recombinant spider silk technology utilizing genetically enhanced
silkworms, unlocks the door for large-scale adoption of spider silk for biomedical applications. This system merges the performance of spider silk with the well-established, large-scale supply chain for mundane silk. With the growth of its production operations in Vietnam over the last two quarters, the Company is now positioned to allot a portion of its spider silk production to address the medical community's needs. This week's shipments are just the first in what the Company hopes will be a significant mid to long-term market growth opportunity for Kraig Labs and its foray into the growing field of bioengineering.
Kraig Biocraft Laboratories, Inc. develops fibers using recombinant deoxyribonucleic acid (DNA) technology for commercial applications in technical textiles. The Company uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its primary fiber technology includes natural and engineered variants of spider silk produced from domesticated mulberry silkworms. The Companyâs products use the characteristics of spider silk, specifically dragline silk from Nephila clavipes and variants thereof. Its recombinant spider silk fiber blends the silk proteins found in spider silk with the native silkworm silk proteins. Its products include Monster Silk, Dragon Silk, and other products. Its applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics and more. The Company also focuses on developing various recombinant silks and other protein-based fibers and materials.